Drug CategoryDrugIHD Dosing

Administration Timing Around HD Session

AntibioticsAmikacinLD 5-7.5mg/kg IV, then 5mg/kg IV QHDAdminister Post-HD

Molecular Weight    (Da)

Excreted Unchanged (%)Normal Half-Life (Hours)ESRD Half-Life (Hours)Plasma Protein Binding (%)Volume of Distribution (L/kg)Dialytic Plasma Clearance (ml/min)% Dialyzed
586951.4-2.317-150<50.22-0.2921.5-125.618.5-88 (low flux)


  • Armstrong D, Hodgman T, Visconti J, et al. Hemodialysis of amikacin in critically ill patients. Critical Care Medicine 1988; 16(5), 517-521.
  • Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug Prescribing in Renal Failure. Philadelphia: American College of Physicians;2007.
  • DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL:
  • Heintz B, Matzke G, Dager W. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy 2009; 29(5), 562-77.
  • Kihara M, Ikeda Y, Takagi N, et al. Pharmacokinetics of single-dose intravenous amikacin in critically ill patients undergoing slow hemodialysis. Intensive care medicine 1995; 21(4), 348-51.
  • Launay-Vacher V, Izzedine H, Deray G. Pharmacokinetic considerations in the treatment of tuberculosis in patients with renal failure. Clinical pharmacokinetics 2005; 44(3), 221-35.
  • Madhavan T, Yaremchuk K, Levin N et al. Effect of Renal Failure and Dialysis on the Serum Concentration of the Aminoglycoside Amikacin. Antimicrobial agents and chemotherapy 1976; 10(3), 10-13.
  • Matzke G. Status of Hemodialysis of Drugs in 2002. Journal of Pharmacy Practice 2002; 15(5), 405-418.
  • Plantier J, Forrey A, Neill M et al. Pharmacokinetics of Amikacin in Patients with Normal or Impaired Renal Function : Radioenzymatic Acetylation Assay. Journal of Infectious Diseases 1976; 134(Supplement), 323-330.
  • Regeur L, Colding H, Kampmann J, Jensen H. Pharmacokinetics of Amikacin During Hemodialysis and Peritoneal Dialysis. Antimicrobial agents and chemotherapy 1977; 11(2), 214-8.
  • Turnidge J. Pharmacodynamics and dosing of aminoglycosides. Infectious Disease Clinics of North America 2003; 17(3), 503-528.